House, Stacey L <br/><br/>
Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma.  [electronic resource] 

 -  Respiratory medicine  Oct 2015 
 - 1268-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-3064 
<br/><br/><label>Standard No.: </label>10.1016/j.rmed.2015.08.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--administration & dosage<br/>Acute Disease<br/>Administration, Inhalation<br/>Administration, Intravenous<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Adult<br/>Asthma--drug therapy<br/>Bronchodilator Agents--administration & dosage<br/>Double-Blind Method<br/>Dyspnea--drug therapy<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Ipratropium--administration & dosage<br/>Male<br/>Middle Aged<br/>Naphthalenes--administration & dosage<br/>Prednisone--administration & dosage<br/>Prospective Studies<br/>Spirometry<br/>Treatment Outcome